INTRODUCTION
============

Given recent technical advances, cardiac magnetic resonance (CMR) imaging is widely used in many areas of cardiovascular disease assessment ([@B1]). Currently, health insurance in Korea covers CMR for cardiomyopathy and complex congenital heart disease, though insurance coverage is expected to expand further in 2019, which will probably increase the number of tests compared with the past.

In 2010, the Asian Society of Cardiovascular Imaging published standardized protocols for CMR imaging ([@B2]) and in 2013 the Society for Cardiovascular Magnetic Resonance published an updated version of the standardized protocols ([@B3]).

Herein, we offer a practical standard CMR protocol for beginners designed to be easy to follow and implement. This protocol guideline is based on previously reported CMR guidelines ([@B1][@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9]) and includes sequence terminology used by vendors, essential MR physics ([@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17]), imaging planes ([@B2][@B18]), field strength considerations ([@B19][@B20][@B21][@B22][@B23][@B24][@B25]), MRI-conditional devices ([@B10][@B20][@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33]), drugs for stress tests ([@B34]), various CMR modules ([@B16][@B35][@B36][@B37][@B38][@B39][@B40][@B41][@B42][@B43][@B44][@B45][@B46]), and disease/symptom-based protocols ([@B47][@B48][@B49][@B50][@B51][@B52][@B53][@B54][@B55][@B56][@B57][@B58]) based on a survey of cardiologists, and various appropriate use criteria. It will be of considerable help in planning and implementing tests. We particularly tried to include useful tips to overcome various practical issues and improve CMR imaging.

By addressing CMR usage and creating this protocol guideline, we are working to continue the standardization and simplification of the patient-based approach to clinical CMR and contribute to the promotion of public health. As CMR imaging technology progresses, we will update this guideline at regular intervals.

This protocol guideline is a joint report of the Korean Society of Cardiovascular Imaging and the Korean Society of Radiology.

General Considerations
======================

Appropriate Criteria
--------------------

CMR imaging is useful in the diagnosis, stratification, treatment planning, prognosis prediction, and therapeutic effect evaluation of various cardiac diseases ([@B53][@B59][@B60]). However, appropriate criteria for disease, ethnicity, socioeconomic status, and the medical insurance system are essential to maximizing its clinical utility ([@B1][@B61]). In 2014, guidelines for the appropriate use of CMR were published jointly by the Korean Society of Cardiology and the Korean Society of Radiology to guide physicians, imaging specialists, medical associates and patients, and improve the overall performance of the health system ([@B1]). In 2017, expert consensus--based, multimodality appropriate-use criteria for noninvasive cardiac imaging were generated ([@B7]). It is necessary to keep up with the latest appropriate criteria. Various clinical scenarios and optimal CMR protocols are provided at the end of this report.

Patient Preparation
-------------------

Adequate patient preparation before a CMR examination is a mandatory part of good CMR practice. Checklists include MR indication, contraindications, informed consent, fasting, food, and medications ([@B2]). A detailed explanation of the exam and instructions on how to breathe should be provided to the patient. Patients should be comfortable during their MR examination. Obtaining an electrocardiogram (ECG) signal is essential to acquiring appropriate MR images ([@B62]). Patient preparation checklists are provided in [Appendix 1](#APP1){ref-type="app"}.

• General tips for patient preparation

1\) In cases of difficulty with breath holding, arrhythmia, or motion artifacts, consider a single-shot module or free breathing with real-time image acquisition.2) In cases of difficulties due to profound respiratory motion, consider an abdominal band to reduce artifacts.3) In cases of difficulties due to pericardial effusion and a weak ECG signal, consider peripheral pulse gating.4) In cases of difficulties due to ghost artifacts caused by pleural effusion and respiratory difficulties, consider postponing the CMR imaging until after pleural effusion drainage.

Sequence Terminology
--------------------

I. MR sequences at a glance1. Spin-echoA. Use a 90° excitation pulse and a 180° re-focusing pulse ([Fig. 1](#F1){ref-type="fig"})B. Advantages1) Robust to off-resonance effects2) Flexible to obtain different contrasts using various time of echo (TE) and time of repetition (TR)C. Disadvantages1) Long acquisition time2) Limited temporal resolution3) Sensitive to motion and flowD. Fast spin-echo (FSE)1) Acquisition times shortened by using a multi-echo approach ([Fig. 2](#F2){ref-type="fig"})2) Turbo spin-echo (TSE), FSE, or rapid acquisition with relaxation enhancement2. Gradient-echo (GRE)A. Use a low flip angle and gradient pulsesB. Advantage: faster image acquisition than spin-echo sequencesC. Disadvantage: low signal to noise ratio (SNR)D. Two strategies1) Spoiled GRE eliminates the remaining transverse magnetization at the end of the TR ([Fig. 3](#F3){ref-type="fig"})a) Strength: fast acquisition of T1 images after injection of contrast agentb) Weakness: saturation of signals when the TR is very short or the flow is very slow2) Balanced steady-state free precession (SSFP) refocuses and reuses the remaining transverse magnetization at the end of the TR ([Fig. 4](#F4){ref-type="fig"})a) Strengths• Signal strength mostly unaffected by blood flow• Rapid image acquisition with a high contrast to noise ratio (CNR)• Bright vessel and cardiac chamber without a contrast agentb) Weakness: sensitive to the off-resonance effect, causing dark band artifactsE. Popular form of CMR due to short acquisition time (better temporal resolution)3. Preparation pulsesA. Inversion pulses1) Invert the longitudinal magnetization ([Fig. 5A](#F5){ref-type="fig"})2) After an inversion pulse, longitudinal magnetization starts to recover toward the equilibrium from the inverted point crossing the nulling point3) Can be used to null the signal of selective objects, such as water, fat, blood, or the myocardiumB. Saturation pulses1) Saturate the longitudinal magnetization to null a net magnetization ([Fig. 5B](#F5){ref-type="fig"})2) After a saturation pulse, longitudinal magnetization starts to recover toward the equilibrium4. Echo-planar imaging (EPI)A. Acquires multiple echoes per excitationB. Can be used with TSE or GREII. Cardiac MRI sequences ([Table 1](#T1){ref-type="table"})1. Spin echo: morphology, anatomy, tumor, etc.2. Gradient echo: cine, perfusion, late gadolinium enhancement (LGE), MR coronary angiography (MRCA)A. Spoiled gradient echo: perfusion, LGE, 3D MRCA with 3.0 tesla (T)B. Balanced SSFP: 2D cine, 3D MRCA with 1.5T3. Inversion recovery: LGE, T1 mapping (Modified look-locker inversion recovery, MOLLI)4. Saturation pulse: first-pass perfusion, fat saturation pulses, T1 mapping (Saturation recovery single-shot acquisition, SASHA)

Imaging Plane
=============

The heart has its own unique axis. CMR should be performed based on the exact planes that meet the purpose of imaging. Even though recent MR machines provide a support system for the CMR imaging plane, clinicians should be familiar with various image axes for accurate imaging interpretation.

Basic Planes
------------

I. Left ventricle (LV) 2-chamber view, LV 4-chamber view, LV short axis view1. Scout imaging or localizer imagingA. Multi-stack transaxial, coronal, and sagittal images should be obtained2. Vertical long axis image ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"})A. Obtained from the transaxial localizer1) Orthogonal to a transaxial scout image at the level of the mitral valve (MV) and tricuspid valve (TV)2) Aligned through the apex and center of the MV3. Horizontal long axis ([Supplementary Fig. 2](#S2){ref-type="supplementary-material"})A. Obtained from vertical long axis images1) Orthogonal to the end-systolic vertical long axis image2) Aligned through the apex and center of the MV4. Short axis image ([Supplementary Fig. 3](#S3){ref-type="supplementary-material"})A. Obtained from vertical long axis images and horizontal long axis images1) Simultaneously orthogonal to vertical long axis images and horizontal long axis images2) Perpendicular to the interventricular septum3) Covers the whole ventricle from the MV to the LV apex at the diastolic phase5. Four-chamber view ([Supplementary Fig. 4](#S4){ref-type="supplementary-material"})A. Obtained from vertical long axis images and the short axis view1) Orthogonal to the vertical long axis images passing through the LV apex and center of the MV2) Aligned through the center of the LV chamber and lower corner of the right ventricle (RV) border on short axis images6. Two-chamber view ([Supplementary Fig. 5](#S5){ref-type="supplementary-material"})A. Obtained from the 4-chamber view and short axis images1) Orthogonal to the 4-chamber view, passing through the LV apex and the center of the MV2) Passing through the mid-LV chamber in the short axis view, parallel to the ventricular septumII. LV 3-chamber view and LV outflow tract (LVOT) long axis1. LV 3-chamber view ([Supplementary Fig. 6](#S6){ref-type="supplementary-material"})A. Obtained from the basal short axis view1) Parallel to the long axis view2) Bisecting MV and apex3) Bisecting LVOT2. LVOT long axis view ([Supplementary Fig. 7](#S7){ref-type="supplementary-material"})A. Obtained from a true axial scout image1) Slice through the aortic root toward the LV apexIII. RV1. RV short axis ([Supplementary Fig. 8](#S8){ref-type="supplementary-material"})A. Obtained from the RV 2-chamber view and 4-chamber view1) Orthogonal to the RV 2-chamber view and 4-chamber view2) Perpendicular to the interventricular septum3) Covers the whole ventricle from the TV to the RV apex at the diastolic phase2. Right ventricle outflow tract (RVOT) view ([Supplementary Fig. 9](#S9){ref-type="supplementary-material"})A. Obtained from an axial scout image1) Slice through the center of the main pulmonary artery (MPA) and the RV apex

Specific Planes
---------------

I. MV view ([Supplementary Fig. 10](#S10){ref-type="supplementary-material"})1. Can be obtained from the 2-chamber view and 4-chamber viewA. Plane is parallel to the MV in the middle of the MVII. TV ([Supplementary Fig. 11](#S11){ref-type="supplementary-material"})1. Can be obtained from the 2-chamber view and 4-chamber viewA. Plane is parallel to the TV in the middle of the TVIII. Aortic valve (AV) view ([Supplementary Fig. 12](#S12){ref-type="supplementary-material"})1. Can be obtained from the 3-chamber and LVOT viewsA. Plane is parallel to the AV just above the AVIV. Pulmonic valve (PV) view1. Can be obtained from the two orthogonal RVOT viewsA. Plane is parallel to the PV just above the PVV. MPA view ([Supplementary Fig. 13](#S13){ref-type="supplementary-material"})1. Can be obtained from two orthogonal views, which are parallel to the MPA2. Plain is perpendicular to the MPA flowVI. Right pulmonary artery (RPA) and left pulmonary artery (LPA) views ([Supplementary Fig. 14](#S14){ref-type="supplementary-material"})1. Plain is perpendicular to the RPA or LPA flow, 1--1.5 cm distal to the MPA bifurcation

Special Considerations and Patient Safety
=========================================

Field Strength Considerations
-----------------------------

I. The popularity of 3T CMR1. 3T MR applications become increasingly used. Furthermore, many new MR-conditional devices can be used in 3T2. AdvantagesA. Increased SNRB. Increased spatial and/or temporal resolution3. WeaknessesA. Increase in inhomogeneities of the radio-frequency (RF) excitation fieldB. Increase in the effect of magnetic susceptibility artifactsC. Increase in the specific absorption rate (SAR)II. Safety1. No definite safety guideline for performing 3T MRI in patients with a cardiac implantation electronic device (CIED)2. Careful 3T MRI is necessary, including pre-MRI reprogramming of the device monitoring, supervision, and follow-upIII. RF exposure1. SARA. RF energy absorbed by the bodyB. Measured in watts per kilogram (W/kg)C. Depends on patient size and weight2. B~1+RMS~A. Root mean square (RMS) of the time-averaged B~1+~ magnetic fieldB. Not patient-dependent, but related to pulse sequencesC. Can be used for implant heating3. Ways to reduce SAR and B~1+RMS~A. Higher degrees of parallel imagingB. Refocusing flip-angle modulation techniques1) Frequency-selective inversion-recovery2) Reduction of flip angleIV. CMR at 3T influences the performance of several sequencesCMR at 3T requires protocol optimization, careful shimming, and adjustment of the RF pulses to prevent artifacts1. Improvements: first-pass perfusion, MR angiography, coronary imaging, myocardial tagging, MR spectroscopy, and fat saturation2. Equivalent to 1.5T: LGE, flow quantification, and black-blood imaging3. Considerable limitation: SSFP4. Main challenges: B0 inhomogeneities, B1 inhomogeneities, off-resonance band artifacts, susceptibility effects, and chemical shift artifacts

Devices
-------

I. CIED in MRI machines1. Common clinical situation2. Historically regarded as a contraindication but no longer an absolute contraindication to MRI3. Adverse interactionsA. Device failure, lead failure, heating, force, torqueB. Magnetic susceptibility artifacts ([Fig. 6](#F6){ref-type="fig"})4. MR-conditional CIEDA. CMR is possible under the adequate workflow protocolB. Consider the device, device insertion duration, scan region, battery power, MR system, and sequencesC. Need cooperation between cardiologists and radiologistsD. MR safety information on the websites1) Medtronic: <https://www.medtronic.com/us-en/healthcare-professionals/mri-resources.html>2) Boston Scientific: <http://www.bostonscientific.com/en-US/customer-service/mri-information.html>3) MRI safety.com: <http://www.mrisafety.com>5. MR-non-conditional CIEDA. Not recommendedB. Can be performed at 1.5T under the supervision of a physician and radiologist, if benefits outweigh the overwhelming risks6. MR-conditional CIED checklists are provided in [Appendix 2](#APP2){ref-type="app"}7. Recommendations to minimize artifacts from a CIEDA. Sufficient distance (\> 6 cm) between the CIED pulse generator and the heart or CIED pulse generator in the right chest wallB. Spoiled GRE sequence with wide bandwidth rather than SSFPC. Change the center offset frequency using the SSFP sequenceD. Long-axis plane for the mid to apical LV and shortaxis plane for the LV base

Drugs
-----

I. Gadolinium-based MRI contrast agents1. Shorten the relaxation times of nuclei within the body2. Nephrogenic systemic fibrosisA. A rare and serious syndromeB. Fibrosis of skin, joints, eyes, and internal organsC. High-risk patients1) Chronic kidney disease stages 4 and 5 (glomerular filtration rate \< 30 mL/min/1.73 m^2^)2) Acute renal failure or chronic liver diseaseD. The gadolinium-containing contrast agents can be divided into three risk groups1) Safest: macrocyclic structurea) Gadoterate, gadobutrol, and gadoteridol2) Intermediate: an ionic linear structurea) Gadopentetate, gadobenate, gadoxetate, and gadofosveset3) Most risky: linear non-ionic structurea) Gadodiamide and gadoversetamide3. Brain depositionA. Gadolinium can lodge in the deep nuclei of the brain, especially when injected repeatedlyB. Macrocyclic agents might accumulate less than linear agentsC. No reliable data about clinical effects or significance4. The Korean Food and Drug Administration recommends the use of a gadolinium-based MRI contrast agent with a macrocyclic structure. In Korea, the supply of gadopentetate, gadodiamide, and gadoversetamide has been discontinued. In the EU, the use of gadolinium-based MRI contrast agents with a linear structure is prohibitedII. Pharmacologic stressors and vasodilators1. DobutamineA. Inotrope1) Directly stimulates β1 receptors in the sympathetic nervous system2) Increases myocardial oxygen demand → promotes myocardial ischemia3) Increases heart rate, blood pressure, and contractility similar to exercise4) Half-life: approximately 2 minutes5) Typical maximum dose: 40 µg/kg/minB. Contraindications1) Unstable angina pectoris2) Severe systemic arterial hypertension (≥ 220/120 mm Hg)3) Severe aortic stenosis4) Obstructive hypertrophic cardiomyopathy with hemodynamic significance5) Uncontrolled cardiac arrhythmias6) Uncontrolled congestive heart failure7) Endocarditis8) Myocarditis or pericarditis9) Family history of sudden cardiac death10) Aortic dissection11) High-grade aortic aneurysm12) Mobile thrombus in LV or left atrium2. Adenosine, dipyridamole, and regadenosonA. Vasodilators1) Promote systemic arterial vasodilation to bring about a super-physiologic increase in vascular flow2) Emphasize the difference between normal coronary arteries (which can dilate) and a stenosed coronary artery (which is already maximally dilated)B. Adenosine1) Acts on the vascular smooth muscle surface to cause vasodilation2) Binds non-selectively to A1, A2A, A2B, and A3a) Activation of A2A → coronary vasodilationb) Activation of A1, A2B, and A3 → bronchospasm, atrioventricular block, etc. (unwanted side effects)3) Dose: 0.14 mg/kg/min4) Half-life: 10--30 seconds5) Competitive inhibitors of adenosinea) Aminophylline, theophylline, and other xanthinecontaining foods, such as coffee, tea, cocoa products, and soft drinksb) Should be restricted for approximately 24 hours prior to the study6) Contraindicationsa) Hypersensitivity to adenosineb) Bronchoconstriction or bronchospastic diseasec) 2nd or 3rd degree atrioventricular blockd) Significant sinus bradycardia (resting heart rate \< 45 bpm)e) Systolic blood pressure less than 90 mm Hgf) Severe arterial hypertensiong) Myocardial infarction within 3 daysh) Disease requiring the regular use of inhalers for asthma, sinus arrhythmia, stenotic valvular disease, or carotid artery stenosis7) Antidote: intravenous (IV) aminophyllineC. Dipyridamole1) Inhibits the cellular uptake and metabolism of adenosine → increases the interstitial adenosine concentrationD. Regadenoson1) Higher selectively for A2A activation than adenosine2) Dose: 0.4 mg single injection3) Half-life: 2--3 minutes4) Precautionsa) Restriction of products containing xanthine for 24--36 hours before the testb) No caffeine for at least 6 hours, but ideally 24 hours, before the testc) No tobacco for 4 hours before the test3. Please use checklists to ensure patient safety and image quality ([@B2]).

Exam Modules
============

Cine Imaging
------------

I. Purpose: to assess cardiac wall motionII. Sequences1. Balanced SSFP or spoiled GRE2. Real time cine (patients with poor breath holding or arrhythmia)III. Image parameters1. ECG gating: retrospective rather than prospective2. Slice thickness: 6--8 mm (no gap)3. Temporal resolution: ≤ 45 ms between phases4. Acquired time frames: 25--30 frames/R-R interval5. Parallel imaging: used as availableIV. Tips1. Uses retrospective gating rather than prospective triggeringA. Acquisition of the entire cardiac cycleB. Can select the appropriate segmentC. Arrhythmia rejection2. Banding artifacts ([Fig. 7](#F7){ref-type="fig"})A. More severe on 3T MR than 1.5T due to B0 field inhomogeneityB. Solutions1) Shimminga) Volume shim centered on the left ventricleb) During shimming, minimize motion (e.g., breathe shallowly)2) Shortest TR3) The center frequency is aligned closely with the water resonance frequencyV. Dobutamine stress test1. To evaluate the viability and contractile reserve2. Avoid beta-blockers and nitrates3. Infusion doseA. Start: 10 µg/kg/minB. Increase: 10 µg/kg/min every 3 minutesC. Infusion time: 5--10 minutesD. Target heart rate: 85% of (220 - age)E. Option: if heart rate response is poor, add 0.3 mg of atropine in fractional doses of up to 2 mg1) Contraindications for atropinea) Advanced heart blockb) Glaucomac) Pyloric stenosisd) Obstructive uropathye) Myasthenia gravis4. Caution: indications for stopping the testA. New wall motion abnormality or wall thickening abnormalityB. Systolic blood pressure \> 240 mm Hg or diastolic blood pressure \> 120 mm HgC. Systolic blood pressure decrease of 20 mm Hg or greater below baselineD. Severe chest pain or other intractable symptomsE. Complex cardiac arrhythmias or reaching peak heart rate

Perfusion Imaging
-----------------

I. Purpose: to evaluate myocardial perfusion (ischemia)II. Sequences: saturation-recovery imaging with GRE-EPI hybrid, GRE, or SSFP readout ([Fig. 8](#F8){ref-type="fig"})III. Image parameters1. Slice thickness: 8--10 mm2. In-plane resolution: \< 3 mm3. Two-fold acceleration and readout temporal resolution: \< 100--125 ms (shorter if available)4. Parallel imaging (if available)IV. Scan protocol1. Scout imaging: same as LV structure and function2. Stress myocardial perfusionA. Slices: at least three short-axis slices per heartbeat at the LV base, mid, and apical levels1) To reduce motion artifacts, obtain the apical slice first and the basal slice last during the cardiac cycle2) If possible, add one slice to the 4-chamber or 2-chamber viewsB. Do a rehearsal scan without contrast or vasodilator injection (dry run) to check the image quality and correct the parameters1) At the end expiration2) 5--10 phases to checkC. Vasodilator infusion: adenosine stress perfusion1) Place two IV catheters in each arma) 20 G IV catheter for contrast material injectionb) 20--22 G IV catheter for adenosine infusion2) Adenosine infusiona) 0.14 mg/kg/minutesb) 4--6 minutes continuous infusionc) When the gadolinium has passed through the LV myocardium, the adenosine infusion should be stopped after imaging 50--60 heartbeatsd) Please check the drug section (adenosine, dipyridamole, and regadenoson)3) Antidote: aminophylline, 125 mg in 50 mL normal saline by IV infusion for 5--6 minutesa) Use if chest pain or shortness of breath occursD. Gadolinium contrast agent1) 0.05--0.1 mmol/kg, 3--7 mL/s during the last minute of adenosine infusion2) Saline flush: at least 30 mL (3--7 mL/s)E. Breath-hold: during the early phases of contrast infusion, before contrast reaches the LV cavityF. Readout for 40--60 heartbeats, in which time contrast will have passed through the LV myocardium3. LV function mode between a stress test and resting test while waiting for contrast washout4. Rest myocardial perfusion imagingA. After a washout period of at least 10 minutes for the gadolinium from the stress perfusion imaging to passB. Same protocol for stress perfusion (except for vasodilator infusion)5. LGEV. Tips1. Dark rim artifact ([Fig. 9](#F9){ref-type="fig"})A. Most common artifact with the perfusion moduleB. Commonly occurs at the subendocardial borderC. Can be confused with a perfusion defectD. Related factors1) Limited spatial resolution2) Cardiac motion3) Partial volume artifact4) Higher concentration of the contrast agentE. Solutions1) Low dose of contrast medium2) High spatial resolution (in the phase encoding direction)3) Thin slice thickness4) High field strength5) Fast imaging2. Use the checklists for the adenosine stress test ([@B2])

LGE Imaging
-----------

I. Purpose: to evaluate myocardial viabilityII. Sequences ([Fig. 10](#F10){ref-type="fig"})1. Patients with sufficient respiratory support: 2D segmented inversion recovery GRE or SSFP, phase-sensitive inversion-recovery (PSIR), and 3D sequences2. Patients with poor breath holding: single-shot imaging (SSFP readout)III. Image parameters1. Acquisition duration per R-R interval: below 200 ms2. Slice thickness and slices at the identical location: same as for cine imaging (short- and long-axis views)IV. Scan protocol1. Axis: same as cine imaging2. Contrast medium injection: 0.1--0.2 mmol/kg gadolinium3. Wait at least 10 minutes after administration4. Set inversion time to null normal myocardium using time of inversion (TI) mapV. Tips1. I f the inversion time is inaccurate, use the PSIR sequences2. If the image quality is poor due to motion artifacts or poor breath holding, use single shot LGE ([Fig. 11](#F11){ref-type="fig"})3. Ghosting artifacts with long T1 tissueA. Pericardial effusion, cerebrospinal fluid, and the silicon bag can cause ghosting artifacts1) This ghosting artifact is not a motion artifact2) Solution: single shot LGE

Flow Imaging
------------

I. Purpose: to measure flow velocity and volume1. Measure pulmonary blood flow (Qp)2. Measure systemic blood flow (Qs)3. Pulmonary-to-systemic flow ratio (Qp:Qs)4. Calculate regurgitant fractions5. Calculate the valve area6. Calculate the aortopulmonary collateral flowII. Sequences1. Velocity--encoded cine gradient echoA. Magnitude images provide anatomic informationB. Phase images provide velocity informationIII. Image parameters1. ECG gating: retrospective gating includes the entire diastolic portion of the cardiac cycle2. Slice thickness: 5--8 mm3. In-plane resolution: at least 1/10 of the vessel diameter, 1.3--2.0 mm4. Velocity encoding sensitivity (VENC): adapted to the expected velocities5. Acquired time frames: 25--30 frames/R-R interval6. Average number of signals: 2--3IV. Tips1. Plane: perpendicular to the vessel and distal to valve leaflet tips of interestA. Deviations of more than 15° cause significant errors in the peak velocity and flow rate2. VENC ([Fig. 12](#F12){ref-type="fig"})A. Adjust 10--20% higher than expected peak velocitiesB. A too-low velocity causes aliasingC. A too-high velocity causes noise and inaccurate measurementsD. Usual peak velocities1) Main pulmonary artery: 60--120 cm/s2) Right/left pulmonary artery: 60--120 cm/s3) Ascending aorta: 100--160 cm/s3. TE: as short as possible4. Spatial resolutionA. Sufficient spatial resolution to prevent significant partial volume effectsB. Recommendation: more than 3 pixels across the diameter or more than 8 pixels in the cross-section of the region of interest5. Temporal resolutionA. Sufficient temporal resolution to prevent a smooth pulsatile flow curve and cause inaccuraciesB. Recommendation: acquire a minimum of 20 non-interpolated images during the cardiac cycle

Morphology Imaging
------------------

I. Purpose: to delineate anatomic structuresII. Sequences1. Spin-echo sequence: FSE or TSE techniquesA. TSE black blood preparation pulses: two 180° RF inversion pulses followed by a delay before the spin echo pulse sequenceB. Strength: high CNRC. Weakness: sensitive to motion artifacts2. Half-Fourier acquisition single-shot turbo spin-echo (HASTE)3. Dark blood GRE: less sensitive to artifacts or motionIII. Image parameters1. Slice thickness: 6--8 mm (no gap)2. Black blood inversion preparation pulse: 20 mm3. Echo train length: 15--20IV. Tips1. Breath-hold, pre-contrast segmented FSE or TSE imaging with double inversion recovery: sequence with good CNR preferred2. If motion artifact is significant with FSE or TSE, try HASTE or dark blood GRE3. Optimizing readout time by acquiring multiple images throughout the diastole is essential to minimizing dropout artifactsA. T2 weighted image (T2WI) is prone to be inhomogeneous with readout time changes, which could hamper the appropriate interpretationB. T2 map could be better than T2WI for evaluating myocardial edema

Tissue Characterization: T1 Mapping
-----------------------------------

I. Purpose: to evaluate the absolute T1 value of the myocardiumII. Sequences ([Fig. 13](#F13){ref-type="fig"})1. Inversion recovery-based protocolA. MOLLI or shortened MOLLIB. Strength1) Good SNR, good image quality2) Better precision than SASHAC. Weakness1) Sensitive to heart rate2. Saturation recovery-based protocolA. SASHAB. Strength1) Better accuracy than MOLLI2) Insensitive to heart rateC. Weakness1) High image noise3. Combined: saturation pulse--prepared, heart-rate-independent inversion recovery (SAPPHIRE) sequenceIII. Image parameters1. Slice thickness: 6--8 mm2. In-plane resolution: less than 2 mm3. Acquisition timeA. 9--17 heartbeatsB. Various, depending on the used T1 mapping sequencesIV. Tips1. Need site-specific normative valuesA. Normative mapping values can be affected by various factors, including field strength, vendor, sequence, contrast regime, and patient population (age/sex)1) Reported normal values for native T1 of normal myocardiuma) 1.5T: 930--1052 msb) 3T: 1052--1158 ms2. Native T1 and extracellular volume (ECV) fraction: preferred to partition coefficient and post contrast T13. Contrast media injectionA. Bolus-only protocol for ECV measurement1) Sufficient for most myocardial ECV applications2) A delay of at least 15 minutes is recommended for dynamic equilibriumV. Scan protocol ([Fig. 14](#F14){ref-type="fig"})1. Native T1 mapping is performed prior to contrast2. Post-contrast T1 mapping: perform \>15 minutes after administration of contrast agent3. Blood sampling is required for ECV assessment

Tissue Characterization: T2 Mapping
-----------------------------------

I. Purpose: to evaluate the absolute T2 value of the myocardiumII. Sequences1. Single shot SSFP: T2-prepared single-shot SSFP sequence acquired with different T2 prep timesIII. Image parameters1. Slice thickness: 6--8 mm2. In-plane resolution: less than 2 mm3. Acquisition time: 7 R-RIV. Tips1. Obtain prior to contrast administration

Tissue Characterization: T2\* Mapping
-------------------------------------

I. Purpose1. To evaluate the absolute T2\* value of the myocardium2. To assess cardiac iron deposition in diseases such as thalassemia majorII. Sequences1. Single shot SSFPIII. Image parameters1. Slice thickness: 8--10 mm2. In-plane resolution: less than 2 mmIV. Tips1. Obtain prior to contrast administration

Coronary Angiography
--------------------

I. Purpose: to evaluate coronary artery diseaseII. Sequences1. 1.5TA. SSFP MRCA sequences without injection of gadolinium-based contrast agent2. 3TA. Gradient-echo sequence with the administration of contrast mediumB. SSFP MRCA---not appropriate due to severe banding artifactsC. T2 prep-MRCA without contrast enhancementIII. Advantages compared to coronary computed tomography angiography1. No ionizing radiation2. No iodine contrast agent3. Excellent temporal resolution4. Evaluation of heavily calcified plaquesIV. Image parameters1. Slice thickness: 1--1.5 mm2. In-plane resolution: 1.0 mm or less3. SlicesA. 50--80 slices to encompass vessels of interestB. Adjust trigger delay and acquisition window according to the coronary periodC. Navigator placed over the right hemidiaphragmV. Tips1. Whole heart MRCA: respiratory gating and ECG gating2. Vessel targeted MRCA: can reduce imaging time3. Regular (slow) heartbeat: use mid-diastolic phase4. Arrhythmia or tachycardia: use the systolic phase5. Continuous infusion of contrast medium (3T): can improve SNRVI. Scan protocol1. LV structure and function module2. Horizontal long axis images for the imaging period of the right coronary artery3. MRCA sequence4. Transaxial slices if desired

Disease/Symptom-Based Protocol
------------------------------

Eighteen expert panel members, 9 cardiologists and 9 radiologists who were familiar with cardiac MRI, completed a questionnaire about the appropriate protocol for a variety of clinical situations ([Table 2](#T2){ref-type="table"}). To assess each clinical situation, they gave 9 points if a pulse sequence was necessary and 1 point if it was not necessary. If more than half of the panelists in one group voted in the same manner (A: appropriate \[7--9\]; U: unknown \[4--6\]; I: inappropriate \[1--3\]), it was deemed a consensus. Items without consensus in the first survey reappeared in the second survey, after which consensus was reached on all items. Each score given is the median ([Table 2](#T2){ref-type="table"}).
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The Data Supplement is available with this article at <https://doi.org/10.3348/kjr.2019.0398>.

###### Supplementary Fig. 1

**How to obtain vertical long axis image.** **A.** Transaxial localizer. **B.** Vertical long axis image.

###### Supplementary Fig. 2

**How to obtain horizontal long axis image.** **A.** Vertical long axis image. **B.** Horizontal long axis.

###### Supplementary Fig. 3

**How to obtain short axis image.** **A.** Vertical long axis image. **B.** Horizontal long axis. **C.** Short axis image.

###### Supplementary Fig. 4

**How to obtain 4-chamber view.** **A.** Vertical long axis image. **B.** Short axis image. **C.** 4-chamber view.

###### Supplementary Fig. 5

**How to obtain 2-chamber view.** **A.** 4-chamber view. **B.** Short axis image. **C.** 2-chamber view.

###### Supplementary Fig. 6

**How to obtain left ventricle 3-chamber view.** **A.** Basal short axis view. **B.** 3-chamber view.

###### Supplementary Fig. 7

**How to obtain left ventricle outflow tract (LVOT) long axis view.** **A.** Axial scout image. **B.** LVOT long axis view.

###### Supplementary Fig. 8

**How to obtain right ventricle (RV) short axis view.** **A.** RV 2-chamber view. **B.** 4-chamber view. **C.** RV short axis view.

###### Supplementary Fig. 9

**How to obtain right ventricle outflow tract (RVOT) view.** **A.** Axial scout image. **B.** RVOT view.

###### Supplementary Fig. 10

**How to obtain mitral valve (MV) view.** **A.** 2-chamber view. **B.** 4-chamber view. **C.** MV view.

###### Supplementary Fig. 11

**How to obtain tricuspid valve (TV) view.** **A.** Right ventricle 2-chamber view. **B.** 4-chamber view. **C.** TV view.

###### Supplementary Fig. 12

**How to obtain aortic valve (AV) view.** **A.** 3-chamber view. **B.** Left ventricel outflow tract view. **C.** AV view.

###### Supplementary Fig. 13

**How to obtain main pulmonary artery (MPA) view.** **A, B.** Two orthogonal views, which are parallel to MPA. **C.** MPA view.

###### Supplementary Fig. 14

**How to obtain right pulmonary artery and left pulmonary artery views.** **A.** Right pulmonary artery. **B.** Left pulmonary artery.

![Spin echo sequence.\
RF = radio frequency, TE = time of echo, TR = time of repetition](kjr-20-1313-g001){#F1}

![Fast spin echo sequence.](kjr-20-1313-g002){#F2}

![Spoiled gradient echo sequence.](kjr-20-1313-g003){#F3}

![Balanced steady-state free precession.](kjr-20-1313-g004){#F4}

![Preparation pulses.\
**A.** Inversion recovery pulse (IR). **B.** Saturation recovery pulse.](kjr-20-1313-g005){#F5}

![Magnetic susceptibility artifact by cardiac implantable electronic device.\
Cine image **(A)** and LGE image **(B)** show significant magnetic susceptibility artifact caused by cardiac implantable electronic device. LGE = late gadolinium enhancement](kjr-20-1313-g006){#F6}

![Banding artifact.\
**A.** Cine image of 2-chamber right ventricle view shows severe banding artifact which hampers appropriate interpretation. **B.** After cardiac shimming and TR adjustment, image quality is improved without banding artifact.](kjr-20-1313-g007){#F7}

![First pass perfusion sequence.\
ECG = electrocardiogram, SR = saturation, T~SR~ = SR time](kjr-20-1313-g008){#F8}

![Dark rim artifact during perfusion magnetic resonance imaging.\
Subendocardial dark rims are seen at basal septum on both stress **(A)** and rest **(B)** perfusion images.](kjr-20-1313-g009){#F9}

![LGE sequences.\
Sequences of LGE with magnitude IR **(A)** and phase-sensitive inversion-recovery **(B)**. FA = flip angle, TD = trigger delay, TI = inversion time](kjr-20-1313-g010){#F10}

![Better image quality of single shot LGE in patient with poor breath holding.\
LGE image with two-dimensional segmented inversion recovery gradient-echo **(A)** in patient with poor breath holding shows poor image quality with significant motion artifact. Single shot LGE **(B)** shows much improved image quality with less motion artifact.](kjr-20-1313-g011){#F11}

![VENC effect on phase-contrast flow imaging.\
Very low VENC factor (**A,** VENC factor = 90 cm/s) causes aliasing on phase contrast flow image of ascending aorta. Usual peak of ascending aorta is 100--160 cm/s (**B,** VENC factor = 130 cm/s; **C,** VENC factor = 160 cm/s). Very high VENC factor (**D,** VENC factor = 190 cm/s) causes noise and inaccurate measurement. VENC = velocity encoding sensitivity](kjr-20-1313-g012){#F12}

![T1 mapping sequences.\
T1 mapping sequences with MOLLI **(A)** and SASHA **(B)**. MOLLI = modified look-locker inversion recovery, SASHA = saturation recovery single-shot acquisition](kjr-20-1313-g013){#F13}

![Native T1 map and post T1 map.\
Native T1 map image **(A)** acquired prior to contrast injection provides pixel-wise absolute native T1 values. Post T1 map image **(B)** acquired after administration of contrast agent provides pixel-wise post T1 values. Using native T1 values and post T1 values of myocardium and blood cavity and hematocrit value, extracellular volume fraction of myocardium could be calculated.](kjr-20-1313-g014){#F14}

###### Routine Cardiac MRI Sequence Terminology (Vendor)

![](kjr-20-1313-i001)

  Module                      Sequence                             Siemens          Philips               GE                           Canon
  --------------------------- ------------------------------------ ---------------- --------------------- ---------------------------- ---------------
  Morphology imaging          Black or dark blood imaging          HASTE            Single Shot TSE       Single Shot FSE, FSE-XL IR   FASE
  T1, T2 IR or Triple IR      TSE BB                                                                                                   
  Cine imaging                Bright blood cine and cine tagging   Cine True FISP   Cine bSSFP            FIESTA, CINE, FASTCARD       Cine FFE-SSFP
  SSFP or FFE gradient echo                                                                                                            
  Perfusion imaging           PWI, TSI, EPI                        EPI              TFE/EPI, B-FFE, TFE   EPI-FGR-Multiphase           EPI, SSFP
  LGE imaging                 IR GRE or SSFP, PSIR                 IR TurboFLASH    IR TFE                IR PrepFGRE                  FFESeg IR
  Flow imaging                Velocity-encoded cine imaging        PC               PC                    PC                           PS-TSA

BB = black blood, bSSFP = balanced steady-state free precession, EPI = echo planar imaging, FASE = single-shot turbo spin echo, FFE-SSFP = fast field echo-steady state free precession, FGR = fast gradient recalled acquisition, FGRE = fast gradient echo, FIESTA = fast imaging employing steady-state acquisition, FISP = fast imaging with steady state precession, FLASH = fast low angle shot, FSE = fast spin echo, FSE-XL = fast spin echo-accelerated, GRE = gradient echo, HASTE = half-Fourier acquisition single-shot turbo spin-echo, IR = inversion recovery, LGE = late gadolinium enhancement, PC = phase contrast, PS = phase shift, PSIR = phase-sensitive inversion-recovery, PWI = perfusion weighted image, TSA = time-shift analysis, TSE = turbo spin echo, TSI = time-signal intensity

###### Disease/Symptom-Based Protocol, Based on Questionnaire

![](kjr-20-1313-i002)

                                                   T1   Cine, LV   Cine, Stress   Cine, RV   Perfusion, Stress   LGE   VENC, Flow   T2   T1 Mapping
  ------------------------------------------------ ---- ---------- -------------- ---------- ------------------- ----- ------------ ---- ------------
  Suspected/stable coronary artery disease         6    9          7              7          9                   9     6            5    7
  Acute coronary syndrome                          6    8          2              8          3                   9     5            7    6
  Before coronary revascularization                6    9          7              8          8                   9     5            7    7
  After coronary revascularization                 6    8          7              7          7                   9     6            7    6
  Heart failure                                    7    9          5              9          5                   9     7            9    9
  Valvular heart disease                           6    8          4              8          5                   7     7            5    7
  Infective endocarditis                           4    7          3              7          4                   5     5            5    4
  Hypertrophic cardiomyopathy                      7    9          6              9          7                   9     7            7    9
  Storage disease                                  7    9          5              9          6                   9     6            9    9
  Pericardial diseases                             7    8          3              9          4                   9     6            7    8
  Pregnancy                                        5    7          1              7          3                   3     5            3    3
  Arterial hypertension                            4    4          3              6          3                   9     5            3    4
  Ventricular arrhythmia                           6    9          3              8          5                   9     5            4    7
  Atrial fibrillation                              5    6          3              6          4                   6     5            4    5
  Peripheral artery diseases                       4    6          2              6          3                   3     3            3    3
  Pulmonary hypertension                           5    7          3              9          5                   7     7            3    7
  Acute pulmonary embolism                         3    5          2              7          3                   3     3            3    3
  Aortic diseases                                  5    6          1              5          3                   4     5            2    3
  Non-cardiac surgery: cardiovascular assessment   3    5          3              7          5                   5     5            3    3
  Grown-up congenital heart disease                7    9          5              9          5                   9     8            6    7

Each score given is median. A = appropriate (7--9), U = unknown (4--6), I = inappropriate (1--3). LV = left ventricle, RV = right ventricle, VENC = velocity encoding sensitivity
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